|
Q3 FY2026
As of Apr 30, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q1 FY2026
As of Oct 31, 2025
|
Q4 FY2025
As of Jul 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q2 FY2025
As of Jan 31, 2025
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Trade receivable | |||||||||||||||||||
| GST receivable | |||||||||||||||||||
| Corporate taxes receivable | |||||||||||||||||||
| Subscription receivable | |||||||||||||||||||
| Deferred financing costs | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Deposit on carbon credits purchase | |||||||||||||||||||
| Carbon credits | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Cash held in Trust Account | |||||||||||||||||||
| Class A Common Stock Subject to Possible Redemption | |||||||||||||||||||
| Total cash held in Trust Account | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Equipment | |||||||||||||||||||
| Cryptocurrencies – restricted | |||||||||||||||||||
| Long-term advances | |||||||||||||||||||
| Deferred financing costs, long-term | |||||||||||||||||||
| Deposit on carbon credits purchase, long-term | |||||||||||||||||||
| Investment in associate | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Current liabilities | |||||||||||||||||||
| Accrued offering costs and expenses | |||||||||||||||||||
| Taxes payable | |||||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||||
| Due to Sponsor | |||||||||||||||||||
| Franchise taxes payable | |||||||||||||||||||
| Income taxes payable | |||||||||||||||||||
| Excise tax payable | |||||||||||||||||||
| Class A Common Stock Subject to Possible Redemption | |||||||||||||||||||
| Total excise tax payable | |||||||||||||||||||
| Redemption payable | |||||||||||||||||||
| Promissory note - related party | |||||||||||||||||||
| Accounts payable and accrued liabilities – related parties | |||||||||||||||||||
| Mandatory convertible debentures | |||||||||||||||||||
| Convertible debentures | |||||||||||||||||||
| Nonrelated Party | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total convertible debentures | |||||||||||||||||||
| Default penalty liability on convertible debt | |||||||||||||||||||
| Derivative liabilities | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total derivative liabilities | |||||||||||||||||||
| Warrant liabilities | |||||||||||||||||||
| Stock option liabilities | |||||||||||||||||||
| Stop loss provision liabilities | |||||||||||||||||||
| Promissory note payable | |||||||||||||||||||
| Deferred financing benefit | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Warrant liability | |||||||||||||||||||
| Deferred underwriting fee | |||||||||||||||||||
| Marketing agreement | |||||||||||||||||||
| Convertible debentures, long term | |||||||||||||||||||
| Nonrelated Party | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Class A common stock subject to possible redemption, 1,717,578 shares at redemption value of $11.34 and 10.98 per share as of September 30, 2024 and December 31, 2023, respectively | |||||||||||||||||||
| Class A Common Stock Subject to Possible Redemption | |||||||||||||||||||
| Total class A common stock subject to possible redemption, 1,717,578 shares at redemption value of $11.34 and 10.98 per share as of September 30, 2024 and December 31, 2023, respectively | |||||||||||||||||||
| Shareholders’ deficiency | |||||||||||||||||||
| Common shares (No par value, unlimited common shares authorized; 16,131,164 common shares issued and outstanding) (July 31, 2025 – 3,541,668) | |||||||||||||||||||
| Class A Common Stock Subject to Possible Redemption | |||||||||||||||||||
| Class B Common Stock | |||||||||||||||||||
| Total common shares (No par value, unlimited common shares authorized; 16,131,164 common shares issued and outstanding) (July 31, 2025 – 3,541,668) | |||||||||||||||||||
| Additional paid in capital | |||||||||||||||||||
| Series A preferred stock subscription | |||||||||||||||||||
| Subscription receivable | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Deficit | |||||||||||||||||||
| Total shareholders’ deficiency | |||||||||||||||||||
| Total liabilities and shareholders’ deficiency | |||||||||||||||||||
Loading...